SWX:COPNPharmaceuticals
Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Revenue Update And Share Price Momentum
Cosmo Pharmaceuticals (SWX:COPN) has drawn attention after a strong share price move in recent months, prompting investors to look more closely at how its gastroenterology, dermatology, and healthtech portfolio lines up with current expectations.
See our latest analysis for Cosmo Pharmaceuticals.
At a share price of CHF122.6, Cosmo Pharmaceuticals has logged a 9.66% 1 month share price return and an 81.90% 3 month share price return. The 1 year total shareholder return of 89.84% suggests...